National Center for Global Health and Medicine at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
National Center for Global Health and Medicine brings 3 presentations to IDWeek 2026 in Washington. Its program centres on drug-resistant bacteria, viral infections and sexually transmitted infections. It covers outcomes of carbapenemase-producing Enterobacterales infections across Japan, adenovirus species and culture positivity in adults, and tinidazole for resistant Mycoplasma genitalium.
| Organization | IDWeek 2026 Attendance |
|---|---|
National Center for Global Health and Medicine Tokyo, Japan | |
Poster Thu Oct 22 12:15pm–1:30pm Comparison of Clinical Outcomes between Carbapenemase-Producing Enterobacterles (CPE) and Non-CPE Infections in Japan: A multicenter study from MultiDrug-Resistant organisms clinical research network (MDRnet) Poster Sat Oct 24 12:15pm–1:30pm Species-Specific Clinical Features and Viral Culture Positivity in Human Adenovirus Infection among Adults: A Detailed Clinical Analysis Talk Sat Oct 24 2:45pm–3:00pm Tinidazole-Based Nitroimidazole Therapy for Resistant Mycoplasma genitalium Infection: A Single-Arm, Open-Label Interventional Study Antimicrobials, resistance and stewardshipHIV, sexually transmitted infections and viral hepatitis |
Instantly find 20 buyers from National Center for Global Health and Medicine
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction